Review highlights advances in non-invasive cardiac output monitoring in pediatric congenital heart disease, indicating potential for safer and earlier detection of low cardiac output syndrome.
Purpose of review Cardiac output (CO) is a fundamental physiological parameter that measures the volume of blood that is pumped by the heart per unit of time, and helps define how oxygen is delivered to the tissues of the human body. In this paper, we discuss current methods of continuous CO monitoring while defining low CO syndrome (LCOS) and how analytical tools may help improve CO management in the subpopulation of patients with congenital heart disease (CHD). Recent findings Non-invasive methods of measuring CO have become increasingly available in recent years. Advantages of non-invasive over invasive techniques include decreased risk of procedural complications, decreased exposure to sedative and/or anesthetic agents, and increased patient comfort. Pediatric patient populations are particularly sensitive to the risks and complications of invasive techniques given the relative size of current technologies to pediatric vascular and cardiac dimensions. Summary Novel device technologies, combined with emerging analytical techniques, may help improve measurement of CO in children and those with CHD, and allow earlier detection of LCOS.
No takes yet. Share an insight, caveat, or question.
Tandon et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: